107 related articles for article (PubMed ID: 8154887)
1. [Study of 5'-DFUR treatment as postoperative adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)].
Yamaguchi A; Maeda A; Hachisuka K; Yura J; Honda K; Honda H; Yoshizaki S; Tsuruga N; Nakazato H
Gan To Kagaku Ryoho; 1994 Apr; 21(5):621-6. PubMed ID: 8154887
[TBL] [Abstract][Full Text] [Related]
2. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant chemotherapy after curative resection for gastric cancer-5'-DFUR + cisplatin vs 5'-DFUR].
Fujitani K; Kobayashi K; Tamaki Y; Tsujinaka T; Hirao M
Gan To Kagaku Ryoho; 2002 Jan; 29(1):61-5. PubMed ID: 11816479
[TBL] [Abstract][Full Text] [Related]
4. [A randomized controlled trial of postoperative adjuvant chemotherapy for colorectal cancer-optimal duration of the treatment].
Hirata K; Nakahara S; Shimokobe T; Imamura T; Sakamoto Y; Hirano T; Abe R; Kuroki N; Konomi K; Kato H; Fujiwara H; Fukuyama N; Hotokezaka M; Miyazaki Y; Terasaka R; Shiraishi M; Miyazaki R; Iwashita A; Nakano S; Ito H
Gan To Kagaku Ryoho; 2009 Jan; 36(1):77-82. PubMed ID: 19151567
[TBL] [Abstract][Full Text] [Related]
5. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
Nakano Y; Ohota J; Fujita M; Taguchi T
Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
[TBL] [Abstract][Full Text] [Related]
8. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapy of high dose 5'-DFUR+MMC for advanced or recurrent gastric cancer. 5'-DFUR Joint Research Group in the Osaka District for Gastric Cancer].
Nakata E; Okajima K; Ishida Y; Munetomo Y; Gotoh K; Toyohara M; Miyazaki H; Matsunaga S; Maeura Y; Fujimura T
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1799-806. PubMed ID: 7574813
[TBL] [Abstract][Full Text] [Related]
10. [A progressive gastric cancer in which preoperative oral chemotherapy resulted in a histopathological "Grade 2" rating].
Hiromoto M; Yasui A; Nishida Y; Kumagai K; Sanada Y; Masuo K; Kobayashi K; Nakayama A
Gan No Rinsho; 1990 May; 36(6):747-51. PubMed ID: 2140866
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024
[TBL] [Abstract][Full Text] [Related]
12. [Survival of 2 years and 7 months with 5'-DFUR treatment in a patient with peritoneal gastric cancer recurrence].
Tamiya Y; Oyamatu M; Matubara Y
Gan To Kagaku Ryoho; 2001 Jan; 28(1):91-4. PubMed ID: 11201388
[TBL] [Abstract][Full Text] [Related]
13. Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis.
Ogata Y; Torigoe S; Matono K; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Mizobe T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
Int Surg; 2007; 92(6):314-9. PubMed ID: 18402123
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy of doxifluridine plus mitomycin C for colorectal lung metastasis--phase II study].
Ike H; Sadahiro S; Oya K; Otani Y; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T;
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1263-8. PubMed ID: 11579637
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced gastric cancer successfully treated with neoadjuvant chemotherapy of combined weekly paclitaxel and doxifluridine (5'-DFUR)].
Hikino H; Yamada T; Hata T; Nakamura K; Sugimoto S; Kanazawa A; Tokuka A; Ozaki N; Nagaoka S
Gan To Kagaku Ryoho; 2004 Apr; 31(4):597-9. PubMed ID: 15114707
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of pre-operative administration of TS-1 in patients with advanced gastric or colorectal cancer--estimation of pathological effectiveness for postoperative adjuvant chemotherapy with TS-1].
Nakano K; Koizumi H; Okugawa K; Nakamura K; Osaka Y; Tsuchiya K; Sako H; Tanabe S; Nakane Y
Gan To Kagaku Ryoho; 2005 Mar; 32(3):329-33. PubMed ID: 15791815
[TBL] [Abstract][Full Text] [Related]
18. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
[TBL] [Abstract][Full Text] [Related]
20. [A markedly effective combination therapy of 5'-DFUR and MMC in advanced gastric cancer--a case report].
Watanabe S; Mayama M; Oguro M; Wakatsuki S; Majima H
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2105-8. PubMed ID: 2145807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
